The global Hematopoietic Stem Cell Transplantation (HSCT) market size is expected to reach USD 4,391.0 million by 2030, registering a CAGR of 11.2% from 2023 to 2030, according to a new report by Coherent Market Insights Inc. The transplantation of multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow, or umbilical cord blood into a patient is known as hematopoietic stem cell transplantation.
The increasing number of hematopoietic stem cell transplants is anticipated to drive market growth in the forecast period.
For example, as per the Transplant Activity Report by the Center for International Blood and Marrow Transplant Research, the number of peripheral blood hematopoietic cell transplants (HCTs) carried out in the United States is as follows:
Request Sample Report + All Related Graphs & Charts:
https://www.coherentmarketinsights.com/insight/request-sample/1250
We have an updated report [Version – 2023] available.
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Top Key Players:
★ Pluristem Therapeutics Inc.
★ CellGenix GmbH
★ Regen Biopharma Inc.
★ Lonza Group
★ Kiadis Pharma
★ Taiga Biotechnologies Inc.
★ Takeda Pharmaceutical Company Limited
★ Escape Therapeutics Inc.
★ Bluebird Bio
★ Talaris Therapeutics Inc.
★ Marker Therapeutics Inc.
★ Stempeutics Research Pvt Ltd.
Detailed Segmentation :
- By Transplant Type:
- Allogeneic
- Autologous
By Indication:
-
- Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
- Hodgkin lymphoma (HL)
- Non-Hodgkin Lymphoma (NHL)
- Multiple Myeloma (MM)
- Other Non-Malignant Disorders
By Application:
-
- Bone Marrow Transplant (BMT)
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Cord Blood Transplant (CBT)
We Offer Customized Report, Click:
https://www.coherentmarketinsights.com/insight/request-customization/1250
Leukemia and lymphoma cases are increasing, which is propelling the market for hematopoietic stem cell transplants worldwide.
Leukemia and lymphoma cases are increasing, which is propelling the market for hematopoietic stem cell transplants worldwide.
The hematopoietic stem cell transplantation (HSCT) market is expected to experience growth due to the rising demand for this procedure driven by the increasing incidence rate of leukemia, lymphoma, and myeloma in the U.S. According to the Leukemia and Lymphoma Society’s 2019 report, approximately 176,200 individuals in the U.S. were diagnosed with these conditions, and 1,399,180 individuals were living with them.
The lack of physical activity, obesity, and poor nutrition in economically developed economies such as the U.S. and Europe contribute to one-third of global cancer cases, according to the World Cancer Research Fund’s 2018 report. Additionally, the report states that leukemia predominantly affects individuals in middle age, with around 90% of cases developing as a result of aging.
The market growth of hematopoietic stem cell transplantation is likely to be hindered by the adverse effects it has on different organs and body parts such as the gastrointestinal tract, mouth, heart, and lungs. These side effects are usually linked to the conditioning regimen, while graft vs. host disease is considered a severe complication.
GVHD is a common complication of allogeneic and reduced-intensity allogeneic stem cell transplantations, wherein the grafted cells attack and damage the patient’s healthy cells, considering them as foreign. Although a close match between donor and patient lowers the risk of GVHD, it cannot eliminate it completely. The disease can manifest in varying degrees of severity, from mild to life-threatening.
The increasing prevalence of leukemia, lymphoma, or myeloma has made North America the leading region in the hematopoietic stem cell transplantation market. In 2017, an estimated 172,910 individuals in the U.S. were diagnosed with these diseases, as reported by the Leukemia and Lymphoma Society. As a result, the use of stem cells for effective treatment has been on the rise in this region.
The Asia Pacific region is anticipated to experience the highest growth rate during the forecast period due to the increasing number of hematopoietic stem cell transplants (HSCT) in the region. As an example, the Japanese Data Center for Hematopoietic Cell Transplantation reported the following number of transplants conducted in Japan
Purchasing the Hematopoietic Stem Cell Transplantation (HSCT) Market:
➣ Outlook for the worldwide Hematopoietic Stem Cell Transplantation (HSCT) market in both developed and emerging markets, both now and in the future.
➣ Both the market segment with the largest projected share and the market segment with the highest CAGR throughout the projection period.
➣ Countries and regions anticipated to experience the fastest development throughout the projected period.
➣ The most recent innovations, market shares, and business tactics used by the key market participants.
➣ Study examines emerging market trends as well as the likelihood that various trends will impact expansion.
➣ Analysis also discusses the factors, challenges, and opportunities that will have a significant impact on the global Hematopoietic Stem Cell Transplantation (HSCT) industry.
➣ Research includes a detailed analysis of market statistics as well as historical and current growth conditions in order to provide futuristic growth estimates.
Purchase This Complete Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/1250
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Hematopoietic Stem Cell Transplantation (HSCT) Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Hematopoietic Stem Cell Transplantation (HSCT) Industry Impact
Chapter 2 Global Hematopoietic Stem Cell Transplantation (HSCT) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Hematopoietic Stem Cell Transplantation (HSCT) (Volume and Value) by Type
2.3 Global Hematopoietic Stem Cell Transplantation (HSCT) (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Hematopoietic Stem Cell Transplantation (HSCT) Sales, Consumption, Export, Import by Regions (2017-2023)
Chapter 5 North America Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
Chapter 6 East Asia Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
Chapter 7 Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
Chapter 8 South Asia Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
Chapter 9 Southeast Asia Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
Chapter 10 Middle East Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
Chapter 11 Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
Chapter 12 Oceania Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
Chapter 13 South America Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
Chapter 14 Company Profiles and Key Figures in Hematopoietic Stem Cell Transplantation (HSCT) Business
Chapter 15 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast (2023-2030)
Chapter 16 Conclusions
Explore More Related Insights:
Stem Cell Cartilage Regeneration Market
Hunter Syndrome Treatment Market
Lysosomal Acid Lipase Deficiency Treatment Market
Personalized Cell Therapy Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame
CA 94010, United States
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837